United States · Series A startup

Who invested in Envisia Therapeutics

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$46Mraised across 3 rounds since 2013, from 3 sources

$25MSeries A$4.6MDebt$17MSeries A
Latest round
Series A, $17MMar 2016
Biggest round
$25MSeries A · Nov 2013
Step-upi
3.6×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420152016
$25MSeries A$4.6MDebt$17MSeries A
First round
Series A, $25M
Nov 2013
Biggest round
$25M
Series A · Nov 2013
Usual gap between rounds
23 months
the median of 2

The rounds

  1. Mar 2016
    Series A$17M3 returning

    Source recordedSEC filing: $10M sold, first sale Mar 2016

  2. Oct 2015
    Debt$4.6M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.6M sold, first sale Oct 2015

  3. Nov 2013
    Series A$25M5 new

    Reported by ca.finance.yahoo.comSEC filing: $15M sold, first sale Nov 2013

Founders and team

From the SEC filings it signed: 2 on the team.

  • Ben YerxaExecutive Officeri
  • Eric LinsleyExecutive Officeri

On the board, as filediAdrienne GravesEd MathersGary PhillipsNeal FowlerStephen BlochWilliam Yelle

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

CanaanVC firm2rounds
Morningside GroupVC firm2rounds
Pappas VenturesVC firm1round
Wakefield GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Envisia Therapeutics

Who invested in Envisia Therapeutics?

Envisia Therapeutics's investors include New Enterprise Associates, Canaan, Morningside Group, Pappas Ventures and Wakefield Group.

How much has Envisia Therapeutics raised?

Envisia Therapeutics has raised $46M across 3 rounds since 2013.

When did Envisia Therapeutics last raise?

Envisia Therapeutics's most recent round was a Series A of $17M in Mar 2016.

What was Envisia Therapeutics's biggest round?

Envisia Therapeutics's largest round on record is $25M (Series A), in Nov 2013.

Who backed Envisia Therapeutics first?

Envisia Therapeutics's first round on record, in Nov 2013, was backed by New Enterprise Associates, Canaan and Morningside Group and 2 others.

What stage is Envisia Therapeutics at?

Envisia Therapeutics's latest named round is a Series A, in Mar 2016.

Where is Envisia Therapeutics based?

Envisia Therapeutics is based in the United States.

Companies like Envisia Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.